Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Last Close
May 28 04:00PM ET
37.64
Dollar change
+0.36
Percentage change
0.97
%
Index- P/E- EPS (ttm)-2.67 Insider Own8.08% Shs Outstand144.34M Perf Week-2.79%
Market Cap5.49B Forward P/E- EPS next Y-3.37 Insider Trans-3.81% Shs Float134.17M Perf Month-9.50%
Income-384.50M PEG- EPS next Q-0.98 Inst Own96.92% Short Float6.43% Perf Quarter-20.61%
Sales777.12M P/S7.07 EPS this Y-52.67% Inst Trans-4.52% Short Ratio8.00 Perf Half Y-24.46%
Book/sh2.03 P/B18.51 EPS next Y13.88% ROA-13.61% Short Interest8.63M Perf Year-3.91%
Cash/sh15.11 P/C2.49 EPS next 5Y35.30% ROE-98.20% 52W Range36.56 - 54.44 Perf YTD-25.60%
Dividend Est.- P/FCF- EPS past 5Y- ROI-17.31% 52W High-30.87% Beta0.34
Dividend TTM- Quick Ratio7.28 Sales past 5Y13.97% Gross Margin95.83% 52W Low2.95% ATR (14)1.26
Dividend Ex-Date- Current Ratio7.37 EPS Y/Y TTM-15.53% Oper. Margin-50.05% RSI (14)38.73 Volatility3.58% 3.30%
Employees927 Debt/Eq6.64 Sales Y/Y TTM34.90% Profit Margin-49.48% Recom1.84 Target Price57.56
Option/ShortYes / Yes LT Debt/Eq6.49 EPS Q/Q-12.65% Payout- Rel Volume0.53 Prev Close37.28
Sales Surprise-9.45% EPS Surprise5.12% Sales Q/Q-8.45% EarningsMay 07 BMO Avg Volume1.08M Price37.64
SMA20-5.17% SMA50-9.00% SMA200-16.89% Trades Volume575,454 Change0.97%
Date Action Analyst Rating Change Price Target Change
Apr-10-24Upgrade Wolfe Research Peer Perform → Outperform $58
Jan-02-24Upgrade BofA Securities Neutral → Buy $52 → $62
Oct-23-23Upgrade BofA Securities Underperform → Neutral $33 → $52
Sep-29-23Initiated Raymond James Strong Buy $63
Jul-31-23Upgrade Citigroup Neutral → Buy $36 → $60
Jun-07-23Resumed Piper Sandler Overweight $58
May-04-23Upgrade Citigroup Sell → Neutral $30 → $36
Mar-21-23Initiated Bernstein Underperform $31
Dec-21-22Downgrade Morgan Stanley Overweight → Equal-Weight $56 → $40
Sep-09-22Resumed Morgan Stanley Overweight $57
Today 07:00AM
May-23-24 07:00AM
May-17-24 10:10AM
May-16-24 12:46PM
10:54AM
08:50AM Loading…
08:50AM
08:05AM
07:51AM
07:37AM
07:30AM
07:30AM
07:00AM
May-15-24 07:05AM
May-13-24 07:00AM
May-09-24 06:30AM
03:15PM Loading…
May-08-24 03:15PM
10:59AM
10:39AM
05:20AM
03:40AM
May-07-24 05:02PM
04:43PM
09:30AM
08:10AM
08:07AM
07:07AM
07:00AM
May-06-24 09:15AM
Apr-30-24 10:00AM
Apr-25-24 07:00AM
07:05AM Loading…
Apr-23-24 07:05AM
Apr-07-24 09:48AM
Apr-01-24 07:05AM
Mar-28-24 07:05AM
Mar-25-24 09:09AM
08:18AM
Mar-22-24 11:30AM
Mar-21-24 03:00PM
Mar-17-24 08:50AM
Mar-14-24 10:40AM
Mar-13-24 07:17AM
07:07AM
07:00AM
Mar-06-24 07:30AM
Feb-29-24 09:05AM
Feb-28-24 07:05AM
Feb-22-24 12:12PM
10:59AM
10:29AM
02:20AM
Feb-21-24 11:31AM
09:30AM
08:05AM
07:06AM
07:00AM
Feb-15-24 09:15AM
07:00AM
Feb-14-24 10:00AM
Feb-09-24 10:44AM
Feb-08-24 07:00AM
Feb-07-24 07:05AM
Jan-23-24 01:23PM
Jan-22-24 07:26AM
07:09AM
07:00AM
04:47AM
Jan-18-24 07:58PM
Jan-08-24 08:00AM
07:03AM
Jan-03-24 08:00AM
Dec-30-23 07:01AM
Dec-27-23 10:34PM
Dec-24-23 11:01AM
Dec-21-23 06:55PM
05:45PM
05:35PM
Dec-20-23 01:50PM
07:05AM
Dec-19-23 10:45AM
Dec-18-23 04:01PM
Dec-14-23 04:05PM
Dec-07-23 08:47PM
Nov-16-23 08:00AM
Nov-13-23 09:46AM
Nov-11-23 11:30AM
Nov-09-23 12:42PM
Nov-04-23 01:01PM
Nov-03-23 06:36PM
09:44AM
07:05AM
05:09AM
Nov-02-23 12:36PM
09:30AM
07:19AM
07:00AM
Oct-31-23 10:01AM
Oct-30-23 03:46PM
Oct-26-23 10:02AM
Oct-19-23 07:05AM
Oct-16-23 10:43AM
Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. It operates through the Ionis Core segment. The Ionis Core segment exploits a novel drug discovery platform to generate a pipeline of drugs. The company was founded by Stanley T. Crooke, David J. Ecker, Christopher K. Mirabelli, and Brett P. Monia on January 10, 1989 and is headquartered in Carlsbad, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
WENDER JOSEPH HDirectorMay 09 '24Option Exercise35.5316,000568,480128,079May 13 05:25 PM
KLEIN JOSEPH IIIDirectorMay 03 '24Sale42.716,000256,2770May 07 04:55 PM
Baroldi JosephEVP, Chief Business OfficerApr 16 '24Sale41.604,006166,64119,631Apr 17 05:19 PM
Birchler BrianEVP, Corp and Development OpsApr 16 '24Sale41.6690537,69846,156Apr 17 05:16 PM
Baroldi JosephEVP, Chief Business OfficerApr 15 '24Option Exercise0.0010,838023,637Apr 17 05:19 PM
Birchler BrianEVP, Corp and Development OpsApr 15 '24Option Exercise0.001,875047,061Apr 17 05:16 PM
Monia Brett PChief Executive OfficerFeb 16 '24Sale44.4938717,219173,751Feb 16 07:47 PM
Monia Brett PChief Executive OfficerFeb 02 '24Sale49.3723,5011,160,303174,138Feb 02 07:55 PM
Cadoret-Manier OnaizaEVP, Chf GL Pdt Str & Oper OfcFeb 02 '24Sale49.602,125105,40435,825Feb 02 07:54 PM
HOUGEN ELIZABETH LEVP, Finance & CFOFeb 02 '24Sale49.542,125105,27292,905Feb 02 07:55 PM
Schneider EugeneEVP, Chf Clinical Develop OfcrFeb 02 '24Sale49.592,071102,70149,812Feb 02 07:55 PM
Geary Richard SEVP, Chief Development OfficerFeb 02 '24Sale50.041,96198,13587,334Feb 02 07:54 PM
O'NEIL PATRICK R.EVP CLO & General CounselFeb 02 '24Sale49.671,96197,41048,661Feb 02 07:55 PM
Swayze EricEVP ResearchFeb 02 '24Sale49.561,90794,51334,324Feb 02 07:55 PM
BENNETT C FRANKEVP, Chief Scientific OfficerFeb 02 '24Sale49.521,85391,75279,079Feb 02 07:54 PM
Swayze EricEVP ResearchJan 31 '24Sale52.0010,773560,19632,516Feb 02 07:55 PM
O'NEIL PATRICK R.EVP CLO & General CounselJan 25 '24Sale51.756,450333,78846,802Jan 29 05:34 PM
Monia Brett PChief Executive OfficerJan 25 '24Sale51.752,285118,249151,851Jan 29 05:34 PM
Monia Brett PChief Executive OfficerJan 17 '24Sale50.4232,0591,616,319154,136Jan 18 05:48 PM
HOUGEN ELIZABETH LEVP, Finance & CFOJan 17 '24Sale50.428,683437,77190,890Jan 18 05:48 PM
O'NEIL PATRICK R.EVP CLO & General CounselJan 17 '24Sale50.427,744390,42953,252Jan 18 05:59 PM
Geary Richard SEVP, Chief Development OfficerJan 17 '24Sale50.427,338369,96085,475Jan 18 05:47 PM
BENNETT C FRANKEVP, Chief Scientific OfficerJan 17 '24Sale50.426,745340,06377,323Jan 18 05:44 PM
Swayze EricEVP ResearchJan 17 '24Sale50.426,296317,42543,289Jan 18 05:49 PM
Cadoret-Manier OnaizaEVP, Chf GL Pdt Str & Oper OfcJan 17 '24Sale50.425,564280,52033,810Jan 18 06:07 PM
Schneider EugeneEVP, Chf Clinical Develop OfcrJan 17 '24Sale50.425,482276,38647,850Jan 18 05:48 PM
Birchler BrianEVP, Corp and Development OpsJan 17 '24Sale50.424,497226,72544,582Jan 18 05:55 PM
Baroldi JosephEVP, Chief Business OfficerJan 17 '24Sale50.421,46073,60912,799Jan 18 05:44 PM
Baroldi JosephEVP, Chief Business OfficerJan 17 '24Sale50.4256428,4351,640Jan 18 05:44 PM
Swayze EricEVP ResearchJan 17 '24Sale50.42945485Jan 18 05:49 PM
Baroldi JosephEVP, Chief Business OfficerJan 16 '24Option Exercise0.001,35302,204Jan 18 05:44 PM
Baroldi JosephEVP, Chief Business OfficerJan 16 '24Option Exercise0.003,688014,259Jan 18 05:44 PM
BENNETT C FRANKEVP, Chief Scientific OfficerJan 16 '24Option Exercise0.0018,314084,068Jan 18 05:44 PM
HOUGEN ELIZABETH LEVP, Finance & CFOJan 16 '24Option Exercise0.0022,487099,573Jan 18 05:48 PM
Monia Brett PChief Executive OfficerJan 16 '24Option Exercise0.0068,0840186,195Jan 18 05:48 PM
Cadoret-Manier OnaizaEVP, Chf GL Pdt Str & Oper OfcJan 16 '24Option Exercise0.0015,062039,374Jan 18 06:07 PM
Birchler BrianEVP, Corp and Development OpsJan 16 '24Option Exercise0.0012,080049,079Jan 18 05:55 PM
O'NEIL PATRICK R.EVP CLO & General CounselJan 16 '24Option Exercise0.0020,641060,996Jan 18 05:59 PM
Geary Richard SEVP, Chief Development OfficerJan 16 '24Option Exercise0.0019,852092,813Jan 18 05:47 PM
Swayze EricEVP ResearchJan 16 '24Option Exercise0.0021094Jan 18 05:49 PM
Swayze EricEVP ResearchJan 16 '24Option Exercise0.0017,069049,585Jan 18 05:49 PM
Schneider EugeneEVP, Chf Clinical Develop OfcrJan 16 '24Option Exercise0.0015,162053,332Jan 18 05:48 PM
Schneider EugeneEVP, Chf Clinical Develop OfcrJan 12 '24Option Exercise32.608,000260,80046,170Jan 17 08:51 PM
Schneider EugeneEVP, Chf Clinical Develop OfcrJan 12 '24Sale53.508,000427,99938,170Jan 17 08:51 PM
HOUGEN ELIZABETH LEVP, Finance & CFODec 28 '23Option Exercise47.3445,2252,140,952120,884Jan 02 05:54 PM
PARSHALL B LYNNEDirectorDec 28 '23Option Exercise47.3442,5252,013,134125,113Dec 28 07:18 PM
Swayze EricEVP ResearchDec 28 '23Option Exercise47.3427,1001,282,91459,616Jan 02 05:54 PM
Birchler BrianEVP, Corp and Development OpsDec 28 '23Option Exercise47.3411,500544,41048,028Jan 02 05:54 PM
PARSHALL B LYNNEDirectorDec 28 '23Sale50.1942,5252,134,22382,588Dec 28 07:18 PM
Swayze EricEVP ResearchDec 28 '23Sale50.1927,1001,360,08132,516Jan 02 05:54 PM
PARSHALL B LYNNEDirectorDec 27 '23Option Exercise47.3450,0002,367,000132,588Dec 28 07:18 PM
PARSHALL B LYNNEDirectorDec 27 '23Sale50.2350,0002,511,51582,588Dec 28 07:18 PM
PARSHALL B LYNNEDirectorDec 26 '23Option Exercise47.3425,1131,188,849107,701Dec 28 07:18 PM
Schneider EugeneEVP, Chf Clinical Develop OfcrDec 26 '23Option Exercise47.3425,0001,183,50061,052Dec 28 07:18 PM
O'NEIL PATRICK R.EVP CLO & General CounselDec 26 '23Option Exercise47.3420,825985,85661,180Dec 28 07:18 PM
PARSHALL B LYNNEDirectorDec 26 '23Sale51.4625,1131,292,39082,588Dec 28 07:18 PM
Schneider EugeneEVP, Chf Clinical Develop OfcrDec 26 '23Sale51.4625,0001,286,57536,052Dec 28 07:18 PM
O'NEIL PATRICK R.EVP CLO & General CounselDec 26 '23Sale51.4620,8251,071,71740,355Dec 28 07:18 PM
Monia Brett PChief Executive OfficerDec 21 '23Option Exercise47.3417,500828,450135,611Dec 22 07:11 PM
BENNETT C FRANKEVP, Chief Scientific OfficerDec 21 '23Option Exercise47.3416,113762,78981,867Dec 22 07:11 PM
Geary Richard SEVP, Chief Development OfficerDec 21 '23Option Exercise47.344,112194,66277,073Dec 22 07:11 PM
Monia Brett PChief Executive OfficerDec 21 '23Sale49.2917,500862,577118,111Dec 22 07:11 PM
BENNETT C FRANKEVP, Chief Scientific OfficerDec 21 '23Sale49.2916,113794,21165,754Dec 22 07:11 PM
Geary Richard SEVP, Chief Development OfficerDec 21 '23Sale49.294,112202,68172,961Dec 22 07:11 PM
Monia Brett PChief Executive OfficerDec 20 '23Option Exercise47.346,500307,710124,611Dec 22 07:11 PM
BENNETT C FRANKEVP, Chief Scientific OfficerDec 20 '23Option Exercise47.346,500307,71072,254Dec 22 07:11 PM
Geary Richard SEVP, Chief Development OfficerDec 20 '23Option Exercise47.346,500307,71079,461Dec 22 07:11 PM
Monia Brett PChief Executive OfficerDec 20 '23Sale49.646,500322,643118,111Dec 22 07:11 PM
Geary Richard SEVP, Chief Development OfficerDec 20 '23Sale49.646,500322,64372,961Dec 22 07:11 PM
BENNETT C FRANKEVP, Chief Scientific OfficerDec 20 '23Sale49.646,500322,64365,754Dec 22 07:11 PM
Monia Brett PChief Executive OfficerDec 14 '23Option Exercise47.3424,0001,136,160132,971Dec 18 04:56 PM
BENNETT C FRANKEVP, Chief Scientific OfficerDec 14 '23Option Exercise47.3422,6121,070,45279,756Dec 18 04:55 PM
Geary Richard SEVP, Chief Development OfficerDec 14 '23Option Exercise47.3410,613502,41979,532Dec 18 04:55 PM
Monia Brett PChief Executive OfficerDec 14 '23Sale49.5824,0001,190,019118,111Dec 18 04:56 PM
BENNETT C FRANKEVP, Chief Scientific OfficerDec 14 '23Sale49.5822,6121,121,19565,754Dec 18 04:55 PM
Geary Richard SEVP, Chief Development OfficerDec 14 '23Sale49.5810,613526,23672,961Dec 18 04:55 PM
KLEIN JOSEPH IIIDirectorNov 15 '23Sale50.002,000100,00016,346Nov 17 04:58 PM
Swayze EricEVP ResearchOct 17 '23Sale47.95522,49373Oct 18 06:40 PM
Swayze EricEVP ResearchOct 16 '23Option Exercise0.001250125Oct 18 06:40 PM
Monia Brett PChief Executive OfficerOct 12 '23Sale46.003,770173,420118,111Oct 16 04:35 PM
BENNETT C FRANKEVP, Chief Scientific OfficerSep 28 '23Sale46.504,460207,39065,754Sep 29 05:20 PM
PARSHALL B LYNNEDirectorSep 26 '23Sale45.1310,000451,26882,588Sep 28 06:03 PM
KLEIN JOSEPH IIIDirectorSep 26 '23Sale45.132,00090,25418,346Sep 28 06:03 PM
Diaz Allene M.DirectorAug 01 '23Sale41.0565726,97012,676Aug 03 05:20 PM
KLEIN JOSEPH IIIDirectorJul 18 '23Sale42.003,555149,31020,346Jul 19 06:05 PM
BERTHELSEN SPENCER RDirectorJul 17 '23Option Exercise0.007,1100147,257Jul 19 06:05 PM
WENDER JOSEPH HDirectorJul 17 '23Option Exercise0.007,1100112,079Jul 19 06:08 PM
Diaz Allene M.DirectorJul 17 '23Option Exercise0.005,333013,333Jul 19 06:05 PM
Hayden Michael RDirectorJul 17 '23Option Exercise0.007,110030,219Jul 19 06:05 PM
HERMAN JOAN EDirectorJul 17 '23Option Exercise0.007,110037,330Jul 19 06:05 PM
KLEIN JOSEPH IIIDirectorJul 17 '23Option Exercise0.007,110023,901Jul 19 06:05 PM
LOSCALZO JOSEPHDirectorJul 17 '23Option Exercise0.007,110041,082Jul 19 06:06 PM
PARSHALL B LYNNEDirectorJul 17 '23Option Exercise0.007,110092,588Jul 19 06:06 PM
Monia Brett PChief Executive OfficerJul 07 '23Sale42.2518,650787,953121,724Jul 11 05:07 PM
BERTHELSEN SPENCER RDirectorJun 20 '23Option Exercise28.4711,250320,288140,147Jun 22 05:17 PM
HERMAN JOAN EDirectorJun 12 '23Option Exercise0.003,555030,220Jun 14 04:50 PM